scPharmaceuticals Inc. Announces Recent Progress on FUROSCIX® and Highlights Corporate Objectives
scPharmaceuticals Inc. (SCPH)
Last scpharmaceuticals inc. earnings: 3/24 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
scpharmaceuticals.com
Company Research
Source: Business Wire
Successful completion of human factors program ahead of FUROSCIX NDA resubmission BURLINGTON, Mass.--(BUSINESS WIRE)--scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced a progress update on FUROSCIX® including progress on both the drug and device validation, and the successful completion of the human factors program. FUROSCIX is the Company’s lead program for the treatment of congestion in patients with heart failure and the Company remains on track to resubmit the FUROSCIX New Drug Application (NDA) under the current 505(b)(2) approval pathway with the U.S. Food and Drug Administration (FDA) by mid-year 2020.The Company has successfully completed their human factors validation study of the FUROSCIX On-body Infusor. The validation study included 60 participants including congestive h
Show less
Read more
Impact Snapshot
Event Time:
SCPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SCPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SCPH alerts
High impacting scPharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
SCPH
News
- scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.MarketBeat
- scPharmaceuticals Inc. (NASDAQ: SCPH) had its price target lowered by analysts at Craig Hallum from $16.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business UpdateGlobeNewswire
- scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024GlobeNewswire
- scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024GlobeNewswire
SCPH
Earnings
- 11/13/24 - Miss
SCPH
Sec Filings
- 11/15/24 - Form SC
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- SCPH's page on the SEC website